⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
New Survey: Healthcare Leaders See AI's Promise, But Only 14% Have Fully Integrated It into Decision-Making
globenewswire.com
ACAD
MRK
Scientist.com to Host Expert Webinar on New Approach Methodologies for Drug Discovery and Development
prnewswire.com
MRK
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
businesswire.com
MRK
Patient Monitoring Devices Market worth $76.11 billion by 2031 | MarketsandMarkets™
prnewswire.com
MDT
ABT
DXCM
GEHC
BSX
MASI
BIIB
AMGN
GILD
BMY
MRK
PFE
JNJ
BAX
BOSC
Antibody Partnering Surges into 2026: Q1 Deals Top $36 Billion as Bispecifics and Discovery Platforms Drive Competition
globenewswire.com
ABBV
LLY
MRK
NVS
PFE
SNY
GILD
BMY
JNJ
UCB
Axient Systems BV Awarded the Holland on the Hill Freddy Heineken Award
globenewswire.com
FRO
MRK
IBM
AMZN
Lifespan Portfolio Company Rejuvenate Bio Closes $6 Million Financing and R&D Collaboration with Merck Animal Health
prnewswire.com
MRK
Merck Animal Health to Acquire TARGAN
businesswire.com
MRK
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies
prnewswire.com
MRK
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies
prnewswire.com
MRK